Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2017
Price : $35 *
At a glance
- Drugs Fluvastatin (Primary) ; Pimonidazole
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Oct 2017 Status changed from recruiting to completed.
- 20 Jun 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Sep 2016.